Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sarah L, Scarpace"'
Autor:
Sarah L Scarpace
Publikováno v:
Drugs in Context, Pp 1-7 (2015)
Lung cancer is the third most commonly diagnosed cancer and the leading cause of cancer-related death in the United States. Unlike non-squamous NSCLC, squamous NSCLC rarely harbor epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase
Externí odkaz:
https://doaj.org/article/266dccd9e1ff46f68d41602c2aa9441a
Autor:
Sarah L Scarpace
Publikováno v:
Clinical Therapeutics. 34:1467-1473
Background Eribulin mesylate is a halichondrin B analogue that acts as a nontaxane microtubule dynamics inhibitor. Eribulin was approved in the United States in 2010 for the treatment of metastatic breast cancer for patients who have received at leas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9bccaa7875cfaa48744220442511311
https://doi.org/10.1016/j.clinthera.2012.06.003
https://doi.org/10.1016/j.clinthera.2012.06.003
Publikováno v:
Annals of Pharmacotherapy. 43:1445-1455
Objective: To review the pharmacology, pharmacokinetics, pharmacodynamics, safety, efficacy, and use of denosumab in osteoporosis, breast cancer, prostate cancer, and multiple myeloma. Data Sources: Studies and abstracts were identified through MEDLI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c79bcfbc2193a9865f8b336a17804b54
https://doi.org/10.1345/aph.1m102
https://doi.org/10.1345/aph.1m102
Publikováno v:
Pharmacotherapy. 29:578-592
Head and neck cancers are a heterogeneous group of diseases involving the oral cavity, pharyngeal tube, and larynx. Given the drug therapy options available, clinical pharmacists can play an important role in the care of this patient population. They
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eab8ee5ecd33dd2feec340bc0e6adde
https://doi.org/10.1592/phco.29.5.578
https://doi.org/10.1592/phco.29.5.578
Publikováno v:
JOP : Journal of the pancreas. 8(1)
Acute drug induced hepatitis has not been commonly associated with epidermal growth factor receptor (EGFR) inhibitors. Hepatotoxicity seen with erlotinib, a small molecule tyrosine kinase inhibitor to EGFR, is usually transient with mild elevation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ee151245a47eb3d9f1843b190e12689
https://pubmed.ncbi.nlm.nih.gov/17228132
https://pubmed.ncbi.nlm.nih.gov/17228132
Autor:
Pamela Paplham, Theresa Hahn, Asher A. Chanan-Khan, Hilary N. Roy, Koen van Besien, Sarah L Scarpace, Philip L. McCarthy, K Brown
Publikováno v:
Leukemialymphoma. 46(2)
Thalidomide has been associated with venous thrombotic events, as reported in the post-marketing surveillance reports by Celgene Corporation; as well as case reports in the literature. Seven arterial thrombotic events have been reported in patients r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::518e7716e20bd7df48b52414f4bde21e
https://pubmed.ncbi.nlm.nih.gov/15621807
https://pubmed.ncbi.nlm.nih.gov/15621807
Autor:
Nalini Ramanathan, Jeyanthi Ramanarayanan, Amy I. Jackson, Sarah L Scarpace, Donald Pasquale, Hung Nguyen
Publikováno v:
Blood. 108:4977-4977
When used in the treatment of low-grade lymphoproliferative disorders, common practice is to administer 6 monthly cycles of FLU 25-mg/m2 daily × 5. This practice is reported to cause infections (including opportunistic such as PCP and Listeria) in o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2350f97686fcab35164d9fe654d62f13
https://doi.org/10.1182/blood.v108.11.4977.4977
https://doi.org/10.1182/blood.v108.11.4977.4977